Clinical Study

A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis

Table 1

LRG—treatment for each study visit.

Visit numberTrial timeline/study visitsBlood tests (renal/liver profiles/cholesterol)Blood test (PTH) + extra sampleDietician advicePittsburgh Dialysis Symptoms IndexCommunicare packageBAASISOther events

0−6 weeks to −3 weeksPotential participants identified from patient records
Contact made; PIS provided

1−3 weeksConsent
Washout period commences

2Randomisation
week 0
Randomisation
Commence oral phosphate binding trial medication— sevelamer or lanthanum

31 week after randomisationTitrate trial medication and statins
Discuss symptoms

42 weeks after randomisationTitrate trial medication and statins
Discuss symptoms

53 Weeks after randomisationTitrate trial medication and statins
Discuss symptoms

64 weeks after randomisationTitrate trial medication and statins
Discuss symptoms

75 weeks after randomisationTitrate trial medication and statins
Discuss symptoms

86 weeks after randomisationTitrate trial medication and statins
Discuss symptoms

97 weeks after randomisationTitrate trial medication and statins
Discuss symptoms

108 weeks after randomisation
Review medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1112 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1216 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1320 weeks after randomisationReview medical history
Discuss symptoms Titrate trial medication and statins if necessary

1424 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1528 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1632 weeks after randomisationReview medical history
Discuss symptoms Titrate trial medication and statins if necessary

1736 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1840 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

1944 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

2048 weeks after randomisationReview medical history
Discuss symptoms
Titrate trial medication and statins if necessary

2152 weeks after randomisationReview medical history
Discuss symptoms
Patient’s involvement in the trial ends